These results suggest that these compounds inhibit oxidative stress and ferroptosis by interacting with specific amino acid residues of key target proteins, thereby modulating the System Xc-/GSH/GPX4 pathway and consequently attenuating the neurological damage and cognitive impairment in the CCH model (Figure 14). This evidence concerns the gene GPX4 and Cognitive impairment.